Project Syndicate: Sep. 10, 2013
PALO ALTO – Race can undoubtedly be a tricky subject, with any suggestion of genetic differences among racial groups – beyond superficial characteristics like skin color – potentially invoking memories of the nineteenth-century eugenics movement and its eventual role in Nazi ideology. Now, with drug companies increasingly seeking to develop medications that target particular racial groups, the long-taboo subject of racial genetics has reemerged.
CommentsView/Create comment on this paragraphMuch of the current debate centers on whether race should be a criterion for inclusion in clinical trials – and, by extension, whether drug labeling should mention race specifically. Although the issues are complicated, the solution is simple: follow the data. Read More